布地奈德雾化吸入联合舒利迭对COPD合并感染患者的临床影响分析

Analysis of the Clinical Effect of Aerosol Inhalation of Budesonide Combined with Seretide on Infection of COPD Patients

目的分析布地奈德雾化吸入联合舒利迭对COPD合并感染患者的临床影响。方法选择2016年1月—2017年5月在该院就诊的80例慢性阻塞性肺疾病(COPD)合并感染患者,并分成两组:对照组(40例)和观察组(40例);对照组给予常规雾化药物吸入,观察组在常规治疗基础上给予舒利迭药物吸入治疗;分析两组患者肺功能结果、治疗前后的血气、治疗有效率等数据变化。结果经过治疗,观察组患者的肺功能改善、血气变化明显优于对照组,差异有统计学意义(P<0.05),观察组治疗总有效率是95.00%,对照组总有效率是80.00%,显然对照组低于观察组(P<0.05)。结论对于临床COPD合并感染疾病患者给予布地奈德雾化吸入结合舒利迭,能够有效改善患者临床症状,控制感染的发展,具有很好的临床应用价值。

Objective This paper tries to analyze clinical effects of aerosol inhalation of budesonide combined with seretide in COPD coinfected patients.Methods 80 cases of chronic obstructive pulmonary disease(COPD)patients with infection in this hospital from January 2016 to May 2017 were selected and divided into two groups:the control group(40 cases)and the observation group(40 cases);the control group was given conventional atomization inhalation therapy,the observation group on the basis of the conventional treatment added seretide inhalation;and the lung function results before and after treatment,blood gas,the effective rate of data changes of the two groups were compared.Results After the treatment,the pulmonary function of two groups of patients improved,the blood gas changes in the observation group was better than the control group,the difference was statistically significant(P<0.05),the total efficiency of the observation group was 95.00%,the total efficiency of the control group was 80.00%,the control group was lower than the observation group(P<0.05).Conclusion The clinical infection in patients with COPD disease were given budesonide inhalation combined with seretide can effectively improve the clinical symptoms of patients and control the infection,which has good clinical application value.